Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion

NCT02144662 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Researcher-Subject Relations

Interventions

DRUG: Ranibizumab

Sponsor

St. Marianna University School of Medicine